Biotech & Medtech
Biotech & Medtech news — Tuesday 29 September 2026
26 stories from 3 sources, every one in English. Each links to its publisher.
-
STAT+: At MAHA Summit, a grassroots movement goes corporate
STAT News
WASHINGTON — The Make America Healthy Again movement has changed, if Tuesday’s MAHA Summit is any indication. The insurgent movement that coalesced around mistrust of the health system and corporate influence put on a summit where industry…
-
Tiny Health Secures $33M to Expand Microbiome Testing
MedCity News
Tiny Health’s Series B round was led by B Capital, with participation from Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Denver Ventures, Pave Health Ventures, Alumni Ventures, Gaingels and Pari Passu Ventures…
-
Unite Us, Instacart Link Care Coordination and Grocery Benefits to Scale Food-as-Medicine
MedCity News
Unite Us and Instacart announced Tuesday that they are partnering to connect healthcare organizations’ care coordination efforts with grocery benefits, with the aim of making food-as-medicine programs easier to launch and operate at scale…
-
STAT+: Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseas
STAT News
A growing number of congressional lawmakers are urging the Trump administration to rethink a federal rule going into effect next month over concerns it will prevent Americans from obtaining prescription medicines from licensed…
-
AstraZeneca Places a $2B Bet on a Summit Therapeutics Cancer Drug
MedCity News
AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings AstraZeneca into a growing group of pharmaceutical companies testing the pairing of antibody drug conjugates with…
-
Beam sues 2 biotechs, alleging theft of base editing trade secrets
BioPharma Dive
Beam claimed a former scientist stole confidential information and quietly spun up a rival rare disease treatment at YolTech Therapeutics. Serapha Bio, which licensed that therapy, denies the charges.
-
MedCity Pivot Podcast: A Conversation With AliveCor’s Priya Abani
MedCity News
In this episode of the MedCity Pivot Podcast, CEO Priya Abani talks about the evolution of AliveCor, one of the earliest digital health companies. The post MedCity Pivot Podcast: A Conversation With AliveCor’s Priya Abani appeared first on…
-
STAT+: PhRMA taps Eric Cantor as new CEO
STAT News
WASHINGTON — Eric Cantor, a former GOP House majority leader, will be the next CEO of PhRMA, the lobbying group announced Tuesday. As head of the brand drug industry’s top lobbying group, Cantor will face mounting political pressure on…
-
STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
STAT News
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company that made a deal with VC firms. The allegation comes at a time of escalating tensions…
-
STAT+: Overton won’t get a vote before midterms
STAT News
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Love is Blind is coming to Boston to…
-
Novo to pay Hengrui up to $2.6B for a once-weekly obesity pill
BioPharma Dive
The deal, which hands Novo a challenger to Lilly’s market-leading Zepbound, comes as the Danish drugmaker looks to calm investor fears about its future.
-
UniQure tumbles with latest data for Huntington’s gene therapy
BioPharma Dive
Analysts guessed that investors wanted to see stronger durability results at a four-year check-in of the key trial supporting a potential approval of "AMT-130."
-
STAT+: Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event
STAT News
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers!…
-
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
STAT News
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. I have banned screens for my broken-legged 8-year-old. As a result, I’m hearing all about newly discovered ancient…
-
STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more
STAT News
Top of the morning to you and a fine one it is. Blue skies, cool breezes, and plenty of chirping birds are enveloping the comfy Pharmalot campus, which is cause to fire up the coffee kettle for yet another cup of stimulation. Our choice…
-
ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’
BioPharma Dive
Rather than deplete malfunctioning B cells as many other emerging autoimmune drugs do, Ai3Bio’s therapies are designed to eliminate a particular group of T helper cells.
-
AstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push
BioPharma Dive
The equity investment comes alongside a deal to test Summit’s ivonescimab alongside potentially many AstraZeneca drugs — but doesn’t hand the pharmaceutical company any ownership rights.
-
Researchers slow neurodegeneration in mice by barring T cells from the brain
STAT News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Good morning! To start, a postscript on Anthropic’s biological breakthrough. Last week, the AI company said Claude had…
-
STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years
STAT News
An experimental gene therapy for Huntington’s disease, developed by the biotech company UniQure, continued to slow the progression of the neurodegenerative disease four years after it was surgically implanted into the brains of patients…
-
The Illegal Drug Marketplace in Your Patients’ Pockets
MedCity News
Patients obtaining drugs through social media, medical spas, or telehealth platforms are not the same as patients obtaining drugs through more traditional illicit channels because they often believe what they are receiving is a clinically…
-
Why MAHA wants to make health data much more accessible
STAT News
WASHINGTON — The Make America Healthy Again movement wants your health data. The MAHA Institute, a think tank formed by allies of Robert F. Kennedy Jr. after his appointment as health secretary, held an event on Monday that emphasized the…
-
Opinion: Child health is the national security crisis we keep ignoring
STAT News
Concerns about military readiness, workforce shortages, rising health care costs, affordability, and America’s ability to compete in an increasingly challenging world seem to play on a loop without any sign of progress. Maybe that’s…
-
STAT+: Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms
STAT News
WASHINGTON — Health industry leaders, still contending with the new rules of President Trump’s Washington, are about to face another shift. November’s midterm elections are likely to shake up key health policy debates, from Medicaid…
-
STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare
STAT News
In the last month, manufacturers have announced “breakthrough” status from the Food and Drug Administration for a menagerie of devices: triage algorithms for abdominal CT scans, diagnostic panels for urinary tract infections, and…
-
Opinion: Massive SNAP cuts could mean more children are separated from their families
STAT News
As the largest SNAP cuts in the program’s history have taken effect around the country, at least 1.5 million children have stopped receiving food assistance. The consequences go beyond hunger. Research suggests that when families lose…
-
She’s spent two decades talking to parents who don’t vaccinate their children. Here’s what she’s learned
STAT News
Parents who decline to vaccinate their children have been called selfish and stupid . They’ve even been accused of child abuse . But what if they’re actually acting logically? That’s the conclusion of Jennifer Reich, a sociologist at the…